Simulations Plus Reports Fourth Quarter and Fiscal 2023 Financial Results
US regulators have released financial results for the fourth quarter and annual revenue guidance for 2024, ahead of a third quarter earnings increase. Payments from simulation software and services for pharmaceutical drug discovery and development have been announced.
Source: streetinsider.comPublished on 2023-10-25
Related news
- Embracing ESG : Paving the Path to Sustainable Dealerships
- Federal budget : Here what you need to know
- Simulations Plus Reports Second Quarter Fiscal 2023 Financial Results
- Sustainable development through prism of new trends and increasing legal obligations
- ESG in the United States : A complex landscape | Eversheds Sutherland ( US ) LLP
- Business leaders investing in generative AI , automation to reinvent physical operations : Report
- My hopes and fears for construction ahead of COP26